Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 2/2021

01-02-2021 | Diarrhea | Original Article

A 2-step algorithm combining glutamate dehydrogenase and nucleic acid amplification tests for the detection of Clostridioides difficile in stool specimens

Authors: Chengcheng Liu, Chenjie Tang, Yaping Han, Yuqiao Xu, Fang Ni, Ke Jin, Genyan Liu

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 2/2021

Login to get access

Abstract

The optimized diagnosis algorithm of Clostridioides difficile infection (CDI) is worldwide concerns. The purpose of this study was to assess the toxigenic C. difficile test performance and propose an optimal laboratory workflow for the diagnosis of CDI in mild virulent epidemic areas. Diarrhea samples collected from patients were analyzed by glutamate dehydrogenase (GDH), toxin AB (CDAB), and nucleic acid amplification test (NAAT). We assessed the performance of GDH, the GDH-CDAB algorithm, and the GDH-NAAT algorithm using toxigenic culture (TC) as a reference method. In this study, 186 diarrhea samples were collected. The numbers of TC-positive and TC-negative samples were 39 and 147, respectively. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and kappa of the GDH assay were 100%, 80.3%, 57.4%, 100%, and 0.63; of the GDH-CDAB algorithm were 48.7%, 97.3%, 82.6%, 87.7%, and 0.54; and of the GDH-NAAT algorithm were 74.4%, 100%, 100%, 93.6%, and 0.82, respectively. The GDH-NAAT algorithm has great concordance with TC in detecting toxigenic C. difficile (kappa = 0.82), while the sensitivity of the GDH-CDAB algorithm was too low to meet the demand of CDI diagnosis clinically. GDH-NAAT algorithm is recommended for the detection of toxigenic C. difficile with high specificity, increased sensitivity, and cost-effective.
Literature
1.
go back to reference Rupnik M, Wilcox MH, Gerding DN (2009) Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 7(7):526–536CrossRef Rupnik M, Wilcox MH, Gerding DN (2009) Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 7(7):526–536CrossRef
2.
go back to reference Bartlett JG (2002) Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 346(5):334CrossRef Bartlett JG (2002) Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 346(5):334CrossRef
3.
go back to reference Bartlett JG (2009) Clostridium difficile infection: historic review. Anaerobe 15(6):227–229CrossRef Bartlett JG (2009) Clostridium difficile infection: historic review. Anaerobe 15(6):227–229CrossRef
4.
go back to reference Jones AM, Kuijper EJ, Wilcox MH (2013) Clostridium difficile: a European perspective. J Infect 66(2):115–128CrossRef Jones AM, Kuijper EJ, Wilcox MH (2013) Clostridium difficile: a European perspective. J Infect 66(2):115–128CrossRef
5.
go back to reference Banaei N, Anikst V, Schroeder LF (2015) Burden of Clostridium difficile infection in the United States. N Engl J Med 372(24):2368–2369CrossRef Banaei N, Anikst V, Schroeder LF (2015) Burden of Clostridium difficile infection in the United States. N Engl J Med 372(24):2368–2369CrossRef
6.
go back to reference Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH, Society for Healthcare Epidemiology of A, Infectious Diseases Society of A (2010) Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). 355. Infect Control Hosp Epidemiol 31(5):431–455CrossRef Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH, Society for Healthcare Epidemiology of A, Infectious Diseases Society of A (2010) Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). 355. Infect Control Hosp Epidemiol 31(5):431–455CrossRef
7.
go back to reference Ticehurst JR, Aird DZ, Dam LM, Borek AP, Hargrove JT, Carroll KC (2006) Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol 44(3):1145–1149CrossRef Ticehurst JR, Aird DZ, Dam LM, Borek AP, Hargrove JT, Carroll KC (2006) Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J Clin Microbiol 44(3):1145–1149CrossRef
8.
go back to reference Crobach MJ, Dekkers OM, Wilcox MH, Kuijper EJ (2009) European society of clinical microbiology and infectious diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect 15(12):1053–1066CrossRef Crobach MJ, Dekkers OM, Wilcox MH, Kuijper EJ (2009) European society of clinical microbiology and infectious diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect 15(12):1053–1066CrossRef
9.
go back to reference Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, McFarland LV, Mellow M, Zuckerbraun BS (2013) Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 108(4):478–498 quiz 499CrossRef Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, McFarland LV, Mellow M, Zuckerbraun BS (2013) Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol 108(4):478–498 quiz 499CrossRef
10.
go back to reference Fenner L, Widmer AF, Goy G, Rudin S, Frei R (2008) Rapid and reliable diagnostic algorithm for detection of Clostridium difficile. J Clin Microbiol 46(1):328–330CrossRef Fenner L, Widmer AF, Goy G, Rudin S, Frei R (2008) Rapid and reliable diagnostic algorithm for detection of Clostridium difficile. J Clin Microbiol 46(1):328–330CrossRef
11.
go back to reference Reyes RC, John MA, Ayotte DL, Covacich A, Milburn S, Hussain Z (2007) Performance of TechLab C. DIFF QUIK CHEK and TechLab C. DIFFICILE TOX A/B II for the detection of Clostridium difficile in stool samples. Diagn Microbiol Infect Dis 59(1):33–37CrossRef Reyes RC, John MA, Ayotte DL, Covacich A, Milburn S, Hussain Z (2007) Performance of TechLab C. DIFF QUIK CHEK and TechLab C. DIFFICILE TOX A/B II for the detection of Clostridium difficile in stool samples. Diagn Microbiol Infect Dis 59(1):33–37CrossRef
12.
go back to reference Burnham CA, Carroll KC (2013) Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev 26(3):604–630CrossRef Burnham CA, Carroll KC (2013) Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev 26(3):604–630CrossRef
13.
go back to reference Planche T, Aghaizu A, Holliman R, Riley P, Poloniecki J, Breathnach A, Krishna S (2008) Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. Lancet Infect Dis 8(12):777–784CrossRef Planche T, Aghaizu A, Holliman R, Riley P, Poloniecki J, Breathnach A, Krishna S (2008) Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. Lancet Infect Dis 8(12):777–784CrossRef
14.
go back to reference Eastwood K, Else P, Charlett A, Wilcox M (2009) Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J Clin Microbiol 47(10):3211–3217CrossRef Eastwood K, Else P, Charlett A, Wilcox M (2009) Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J Clin Microbiol 47(10):3211–3217CrossRef
15.
go back to reference Planche T, Wilcox M (2011) Reference assays for Clostridium difficile infection: one or two gold standards? J Clin Pathol 64(1):1–5CrossRef Planche T, Wilcox M (2011) Reference assays for Clostridium difficile infection: one or two gold standards? J Clin Pathol 64(1):1–5CrossRef
16.
go back to reference Collins DA, Hawkey PM, Riley TV (2013) Epidemiology of Clostridium difficile infection in Asia. Antimicrob Resist Infect Control 2(1):21CrossRef Collins DA, Hawkey PM, Riley TV (2013) Epidemiology of Clostridium difficile infection in Asia. Antimicrob Resist Infect Control 2(1):21CrossRef
17.
go back to reference Hawkey PM, Marriott C, Liu WE, Jian ZJ, Gao Q, Ling TK, Chow V, So E, Chan R, Hardy K, Xu L, Manzoor S (2013) Molecular epidemiology of Clostridium difficile infection in a major Chinese hospital: an underrecognized problem in Asia? J Clin Microbiol 51(10):3308–3313CrossRef Hawkey PM, Marriott C, Liu WE, Jian ZJ, Gao Q, Ling TK, Chow V, So E, Chan R, Hardy K, Xu L, Manzoor S (2013) Molecular epidemiology of Clostridium difficile infection in a major Chinese hospital: an underrecognized problem in Asia? J Clin Microbiol 51(10):3308–3313CrossRef
18.
go back to reference Tang C, Li Y, Liu C, Sun P, Huang X, Xia W, Qian H, Cui L, Liu G (2018) Epidemiology and risk factors for Clostridium difficile-associated diarrhea in adult inpatients in a university hospital in China. Am J Infect Control 46(3):285–290CrossRef Tang C, Li Y, Liu C, Sun P, Huang X, Xia W, Qian H, Cui L, Liu G (2018) Epidemiology and risk factors for Clostridium difficile-associated diarrhea in adult inpatients in a university hospital in China. Am J Infect Control 46(3):285–290CrossRef
19.
go back to reference Crobach MJ, Planche T, Eckert C, Barbut F, Terveer EM, Dekkers OM, Wilcox MH, Kuijper EJ (2016) European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect 22(Suppl 4):S63–S81CrossRef Crobach MJ, Planche T, Eckert C, Barbut F, Terveer EM, Dekkers OM, Wilcox MH, Kuijper EJ (2016) European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect 22(Suppl 4):S63–S81CrossRef
20.
go back to reference Dionne LL, Raymond F, Corbeil J, Longtin J, Gervais P, Longtin Y (2013) Correlation between Clostridium difficile bacterial load, commercial real-time PCR cycle thresholds, and results of diagnostic tests based on enzyme immunoassay and cell culture cytotoxicity assay. J Clin Microbiol 51(11):3624–3630CrossRef Dionne LL, Raymond F, Corbeil J, Longtin J, Gervais P, Longtin Y (2013) Correlation between Clostridium difficile bacterial load, commercial real-time PCR cycle thresholds, and results of diagnostic tests based on enzyme immunoassay and cell culture cytotoxicity assay. J Clin Microbiol 51(11):3624–3630CrossRef
21.
go back to reference Arimoto J, Horita N, Kato S, Fuyuki A, Higurashi T, Ohkubo H, Endo H, Takashi N, Kaneko T, Nakajima A (2016) Diagnostic test accuracy of glutamate dehydrogenase for Clostridium difficile: systematic review and meta-analysis. 4259. Sci Rep 6:29754CrossRef Arimoto J, Horita N, Kato S, Fuyuki A, Higurashi T, Ohkubo H, Endo H, Takashi N, Kaneko T, Nakajima A (2016) Diagnostic test accuracy of glutamate dehydrogenase for Clostridium difficile: systematic review and meta-analysis. 4259. Sci Rep 6:29754CrossRef
22.
go back to reference Tang C, Cui L, Xu Y, Xie L, Sun P, Liu C, Xia W, Liu G (2016) The incidence and drug resistance of Clostridium difficile infection in Mainland China: a systematic review and meta-analysis. Sci Rep 6:37865CrossRef Tang C, Cui L, Xu Y, Xie L, Sun P, Liu C, Xia W, Liu G (2016) The incidence and drug resistance of Clostridium difficile infection in Mainland China: a systematic review and meta-analysis. Sci Rep 6:37865CrossRef
23.
go back to reference Altindiş M, Usluer S, Ciftçi H, Tunç N, Cetinkaya Z, Aktepe OC (2007) Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods. Mikrobiyoloji Bülteni 41(1):29–37PubMed Altindiş M, Usluer S, Ciftçi H, Tunç N, Cetinkaya Z, Aktepe OC (2007) Investigation of the presence of Clostridium difficile in antibiotic associated diarrhea patients by culture and toxin detection methods. Mikrobiyoloji Bülteni 41(1):29–37PubMed
24.
go back to reference Rao K, Micic D, Natarajan M, Winters S, Kiel MJ, Walk ST, Santhosh K, Mogle JA, Galecki AT, LeBar W, Higgins PD, Young VB, Aronoff DM (2015) Clostridium difficile ribotype 027: relationship to age, detectability of toxins A or B in stool with rapid testing, severe infection, and mortality. Clin Infect Dis 61(2):233–241CrossRef Rao K, Micic D, Natarajan M, Winters S, Kiel MJ, Walk ST, Santhosh K, Mogle JA, Galecki AT, LeBar W, Higgins PD, Young VB, Aronoff DM (2015) Clostridium difficile ribotype 027: relationship to age, detectability of toxins A or B in stool with rapid testing, severe infection, and mortality. Clin Infect Dis 61(2):233–241CrossRef
25.
go back to reference Vasoo S, Stevens J, Portillo L, Barza R, Schejbal D, Wu MM, Chancey C, Singh K (2014) Cost-effectiveness of a modified two-step algorithm using a combined glutamate dehydrogenase/toxin enzyme immunoassay and real-time PCR for the diagnosis of Clostridium difficile infection. J Microbiol Immunol Infect 47(1):75–78CrossRef Vasoo S, Stevens J, Portillo L, Barza R, Schejbal D, Wu MM, Chancey C, Singh K (2014) Cost-effectiveness of a modified two-step algorithm using a combined glutamate dehydrogenase/toxin enzyme immunoassay and real-time PCR for the diagnosis of Clostridium difficile infection. J Microbiol Immunol Infect 47(1):75–78CrossRef
26.
go back to reference Martinez-Melendez A, Camacho-Ortiz A, Morfin-Otero R, Maldonado-Garza HJ, Villarreal-Trevino L, Garza-Gonzalez E (2017) Current knowledge on the laboratory diagnosis of Clostridium difficile infection. World J Gastroenterol 23(9):1552–1567CrossRef Martinez-Melendez A, Camacho-Ortiz A, Morfin-Otero R, Maldonado-Garza HJ, Villarreal-Trevino L, Garza-Gonzalez E (2017) Current knowledge on the laboratory diagnosis of Clostridium difficile infection. World J Gastroenterol 23(9):1552–1567CrossRef
27.
go back to reference Terveer EM, Crobach MJ, Sanders IM, Vos MC, Verduin CM, Kuijper EJ (2017) Detection of Clostridium difficile in feces of asymptomatic patients admitted to the hospital. 3712. J Clin Microbiol 55(2):403–411CrossRef Terveer EM, Crobach MJ, Sanders IM, Vos MC, Verduin CM, Kuijper EJ (2017) Detection of Clostridium difficile in feces of asymptomatic patients admitted to the hospital. 3712. J Clin Microbiol 55(2):403–411CrossRef
28.
go back to reference Polage CR, Gyorke CE, Kennedy MA, Leslie JL, Chin DL, Wang S, Nguyen HH, Huang B, Tang YW, Lee LW, Kim K, Taylor S, Romano PS, Panacek EA, Goodell PB, Solnick JV, Cohen SH (2015) Overdiagnosis of Clostridium difficile infection in the molecular test era. JAMA Intern Med 175(11):1792–1801CrossRef Polage CR, Gyorke CE, Kennedy MA, Leslie JL, Chin DL, Wang S, Nguyen HH, Huang B, Tang YW, Lee LW, Kim K, Taylor S, Romano PS, Panacek EA, Goodell PB, Solnick JV, Cohen SH (2015) Overdiagnosis of Clostridium difficile infection in the molecular test era. JAMA Intern Med 175(11):1792–1801CrossRef
29.
go back to reference Longtin Y, Trottier S, Brochu G, Paquet-Bolduc B, Garenc C, Loungnarath V, Beaulieu C, Goulet D, Longtin J (2013) Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin Infect Dis 56(1):67–73CrossRef Longtin Y, Trottier S, Brochu G, Paquet-Bolduc B, Garenc C, Loungnarath V, Beaulieu C, Goulet D, Longtin J (2013) Impact of the type of diagnostic assay on Clostridium difficile infection and complication rates in a mandatory reporting program. Clin Infect Dis 56(1):67–73CrossRef
30.
go back to reference Fang FC, Polage CR, Wilcox MH (2017) Point-counterpoint: what is the optimal approach for detection of Clostridium difficile infection? J Clin Microbiol 55(3):670–680CrossRef Fang FC, Polage CR, Wilcox MH (2017) Point-counterpoint: what is the optimal approach for detection of Clostridium difficile infection? J Clin Microbiol 55(3):670–680CrossRef
31.
go back to reference Dallal RM, Harbrecht BG, Boujoukas AJ, Sirio CA, Farkas LM, Lee KK, Simmons RL (2002) Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 235(3):363–372CrossRef Dallal RM, Harbrecht BG, Boujoukas AJ, Sirio CA, Farkas LM, Lee KK, Simmons RL (2002) Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 235(3):363–372CrossRef
32.
go back to reference McFarland LV, Elmer GW, Stamm WE, Mulligan ME (1991) Correlation of immunoblot type, enterotoxin production, and cytotoxin production with clinical manifestations of Clostridium difficile infection in a cohort of hospitalized patients. Infect Immun 59(7):2456–2462CrossRef McFarland LV, Elmer GW, Stamm WE, Mulligan ME (1991) Correlation of immunoblot type, enterotoxin production, and cytotoxin production with clinical manifestations of Clostridium difficile infection in a cohort of hospitalized patients. Infect Immun 59(7):2456–2462CrossRef
33.
go back to reference Anikst VE, Gaur RL, Schroeder LF, Banaei N (2016) Organism burden, toxin concentration, and lactoferrin concentration do not distinguish between clinically significant and nonsignificant diarrhea in patients with Clostridium difficile. Diagn Microbiol Infect Dis 84(4):343–346CrossRef Anikst VE, Gaur RL, Schroeder LF, Banaei N (2016) Organism burden, toxin concentration, and lactoferrin concentration do not distinguish between clinically significant and nonsignificant diarrhea in patients with Clostridium difficile. Diagn Microbiol Infect Dis 84(4):343–346CrossRef
34.
go back to reference Planche TD, Davies KA, Coen PG, Finney JM, Monahan IM, Morris KA, O’Connor L, Oakley SJ, Pope CF, Wren MW, Shetty NP, Crook DW, Wilcox MH (2013) Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection. Lancet Infect Dis 13(11):936–945CrossRef Planche TD, Davies KA, Coen PG, Finney JM, Monahan IM, Morris KA, O’Connor L, Oakley SJ, Pope CF, Wren MW, Shetty NP, Crook DW, Wilcox MH (2013) Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection. Lancet Infect Dis 13(11):936–945CrossRef
Metadata
Title
A 2-step algorithm combining glutamate dehydrogenase and nucleic acid amplification tests for the detection of Clostridioides difficile in stool specimens
Authors
Chengcheng Liu
Chenjie Tang
Yaping Han
Yuqiao Xu
Fang Ni
Ke Jin
Genyan Liu
Publication date
01-02-2021
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 2/2021
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-020-04027-y

Other articles of this Issue 2/2021

European Journal of Clinical Microbiology & Infectious Diseases 2/2021 Go to the issue